Cargando…
Identification of exacerbation risk in patients with liver dysfunction using machine learning algorithms
The prediction of the liver failure (LF) and its proper diagnosis would lead to a reduction in the complications of the disease and prevents the progress of the disease. To improve the treatment of LF patients and reduce the cost of treatment, we build a machine learning model to forecast whether a...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7546449/ https://www.ncbi.nlm.nih.gov/pubmed/33035213 http://dx.doi.org/10.1371/journal.pone.0239266 |
_version_ | 1783592229883871232 |
---|---|
author | Peng, Junfeng Zhou, Mi Chen, Chuan Xie, Xiaohua Luo, Ching-Hsing |
author_facet | Peng, Junfeng Zhou, Mi Chen, Chuan Xie, Xiaohua Luo, Ching-Hsing |
author_sort | Peng, Junfeng |
collection | PubMed |
description | The prediction of the liver failure (LF) and its proper diagnosis would lead to a reduction in the complications of the disease and prevents the progress of the disease. To improve the treatment of LF patients and reduce the cost of treatment, we build a machine learning model to forecast whether a patient would deteriorate after admission to the hospital. First, a total of 348 LF patients were included from May 2011 to March 2018 retrospectively in this study. Then, 15 key clinical indicators are selected as the input of the machine learning algorithm. Finally, machine learning and the Model for End-Stage Liver Disease (MELD) are used to forecast the LF deterioration. The area under the receiver operating characteristic (AUC) of MELD, GLMs, CART, SVM and NNET with 10 fold-cross validation was 0.670, 0.554, 0.794, 0.853 and 0.912 respectively. Additionally, the accuracy of MELD, GLMs, CART, SVM and NNET was 0.669, 0.456, 0.794, 0.853 and 0.912. The predictive performance of the developed machine model execept the GLMs exceeds the classic MELD model. The machine learning method could support the physicians to trigger the initiation of timely treatment for the LD patients. |
format | Online Article Text |
id | pubmed-7546449 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-75464492020-10-19 Identification of exacerbation risk in patients with liver dysfunction using machine learning algorithms Peng, Junfeng Zhou, Mi Chen, Chuan Xie, Xiaohua Luo, Ching-Hsing PLoS One Research Article The prediction of the liver failure (LF) and its proper diagnosis would lead to a reduction in the complications of the disease and prevents the progress of the disease. To improve the treatment of LF patients and reduce the cost of treatment, we build a machine learning model to forecast whether a patient would deteriorate after admission to the hospital. First, a total of 348 LF patients were included from May 2011 to March 2018 retrospectively in this study. Then, 15 key clinical indicators are selected as the input of the machine learning algorithm. Finally, machine learning and the Model for End-Stage Liver Disease (MELD) are used to forecast the LF deterioration. The area under the receiver operating characteristic (AUC) of MELD, GLMs, CART, SVM and NNET with 10 fold-cross validation was 0.670, 0.554, 0.794, 0.853 and 0.912 respectively. Additionally, the accuracy of MELD, GLMs, CART, SVM and NNET was 0.669, 0.456, 0.794, 0.853 and 0.912. The predictive performance of the developed machine model execept the GLMs exceeds the classic MELD model. The machine learning method could support the physicians to trigger the initiation of timely treatment for the LD patients. Public Library of Science 2020-10-09 /pmc/articles/PMC7546449/ /pubmed/33035213 http://dx.doi.org/10.1371/journal.pone.0239266 Text en © 2020 Peng et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Peng, Junfeng Zhou, Mi Chen, Chuan Xie, Xiaohua Luo, Ching-Hsing Identification of exacerbation risk in patients with liver dysfunction using machine learning algorithms |
title | Identification of exacerbation risk in patients with liver dysfunction using machine learning algorithms |
title_full | Identification of exacerbation risk in patients with liver dysfunction using machine learning algorithms |
title_fullStr | Identification of exacerbation risk in patients with liver dysfunction using machine learning algorithms |
title_full_unstemmed | Identification of exacerbation risk in patients with liver dysfunction using machine learning algorithms |
title_short | Identification of exacerbation risk in patients with liver dysfunction using machine learning algorithms |
title_sort | identification of exacerbation risk in patients with liver dysfunction using machine learning algorithms |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7546449/ https://www.ncbi.nlm.nih.gov/pubmed/33035213 http://dx.doi.org/10.1371/journal.pone.0239266 |
work_keys_str_mv | AT pengjunfeng identificationofexacerbationriskinpatientswithliverdysfunctionusingmachinelearningalgorithms AT zhoumi identificationofexacerbationriskinpatientswithliverdysfunctionusingmachinelearningalgorithms AT chenchuan identificationofexacerbationriskinpatientswithliverdysfunctionusingmachinelearningalgorithms AT xiexiaohua identificationofexacerbationriskinpatientswithliverdysfunctionusingmachinelearningalgorithms AT luochinghsing identificationofexacerbationriskinpatientswithliverdysfunctionusingmachinelearningalgorithms |